buyModerate
Arjun Goyal bought $5.9M of CNTA
director at Centessa Pharmaceuticals plc. 462,585 shares at an average of $12.68, traded May 15, 2025, filed May 19, 2025.
Conviction score
48Value
$5.9M
462,585 shares
Holdings after
462,585
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +25Trade size$5.9M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-25-000074, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 15, 2025 | POpen-market purchase Ordinary Sharesindirect: See footnote | +44,939 | $12.24 | $550k | 44,939 | May 19, 2025 |
| May 16, 2025 | POpen-market purchase Ordinary Sharesindirect: See footnote | +417,646 | $12.73 | $5.3M | 462,585 | May 19, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $210k 15,000 shares | -6% | |
| 11Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $168k 12,000 shares | -10% | |
| 6Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $139k 10,000 shares | -8% | |
| 31Weak | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $695k 55,000 shares | -20% | |
| 0Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $128k 10,000 shares | -8% | |
| 24Weak | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $699k 55,000 shares | -20% | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $4,354 311 shares | -0% | |
| 4Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $80k 5,689 shares | -5% | |
| 21Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $160k 11,742 shares | -9% | |
| 46Moderate | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $682k 55,000 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.